Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal Cancer Prognosis
ConclusionOur results suggest that PAR1 expression affects the prognosis and recurrence rate of HPV-associated oropharyngeal cancer.
Source: Head and Neck Pathology - Category: Pathology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Cervical Cancer | Head and Neck Cancer | Hypopharyngeal Cancer | Oropharyngeal Cancer | Pathology